Literature DB >> 17051561

Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Laura E Moreno Luna1, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17051561     DOI： 10.1002/lt.20938

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  8 in total

1.  DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies.

Authors:  Hannah Lee; Peter S Rabinovitch; Aras N Mattis; Sanjay Kakar; Won-Tak Choi
Journal:  Hum Pathol       Date:  2020-04-06       Impact factor: 3.466

Review 2.  Cholangiocarcinoma: has there been any progress?

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Mang Ma; Winnie Wong; Michael B Sawyer; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

3.  Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.

Authors:  Michael H Chapman; Neomal S Sandanayake; Fausto Andreola; Dipok K Dhar; George J Webster; James S Dooley; Stephen P Pereira
Journal:  J Clin Exp Hepatol       Date:  2011-06

Review 4.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

5.  Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.

Authors:  Natasha S Becker; Joel A Rodriguez; Neal R Barshes; Christine A O'Mahony; John A Goss; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2007-10-26       Impact factor: 3.452

6.  Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.

Authors:  Giulia Bonato; Laura Cristoferi; Mario Strazzabosco; Luca Fabris
Journal:  Dig Dis       Date:  2015-12-07       Impact factor: 2.404

7.  Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.

Authors:  Kim Andresen; Kirsten Muri Boberg; Hege Marie Vedeld; Hilde Honne; Merete Hektoen; Chrisopher A Wadsworth; Ole Petter Clausen; Tom Hemming Karlsen; Aksel Foss; Oystein Mathisen; Erik Schrumpf; Ragnhild A Lothe; Guro E Lind
Journal:  Epigenetics       Date:  2012-09-14       Impact factor: 4.528

8.  Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.

Authors:  Eline J C A Kamp; Maikel P Peppelenbosch; Michail Doukas; Joanne Verheij; Cyriel Y Ponsioen; Ronald van Marion; Marco J Bruno; Bas Groot Koerkamp; Winand N M Dinjens; Annemarie C de Vries
Journal:  Clin Transl Gastroenterol       Date:  2021-10-05       Impact factor: 4.488
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.